Author information from the last article
Lowan H. Stewart er spesialist i akuttmedisin, medisinsk leder ved Axonklinikken i Oslo og konsulent for Ketaminenheten ved DPS nordre Østfold i Moss.
Articles by Lowan H. Stewart
Ketamine in treatment-resistant depression
- Mark Berthold-Losleben,
- Ingrid Autran,
- Rikke Lise Steen Folstad,
- Benedikt Römer,
- Tor-Morten Kvam,
- Inger-Tove van de Vooren,
- Lowan H. Stewart,
- Ingmar Claussen,
- Ole A. Andreassen
24.04.2025:
Ketamine has a rapid antidepressant effect and appears to be a safe and effective treatment option for treatment-resistant depression. Depression is a common, serious illness that has a major negative impact on individuals, their families and society. Cardinal symptoms include low mood, loss of...
Ketamine for depression – evidence and proposals for practice
- Tor-Morten Kvam,
- Lowan H. Stewart,
- Andreas Wahl Blomkvist,
- Ole A. Andreassen
25.10.2021:
Current treatment for serious depression is unsatisfactory, and many patients fail to achieve the desired effect. Ketamine represents a new treatment option, and randomised trials show a rapid effect of intravenous ketamine. Although knowledge about adverse effects and the duration of the effect is...
Psychedelic drugs in the treatment of anxiety, depression and addiction
- Tor-Morten Kvam,
- Lowan H. Stewart,
- Ole A. Andreassen
12.11.2018:
In the 1950s and 60s, the classic psychedelic drugs lysergic acid diethylamide (LSD) and psilocybin were tested in numerous clinical trials. The results suggested efficacy against anxiety and depression in cases of life-threatening illness, unipolar depression and addiction (1–3). An open study of...